AN OPEN LABEL, RANDOMISED, REPEAT DOSE STUDY TO ASSESS THE PHARMACOKINETIC PERFORMANCE OF FIVE EZOGABINE/RETIGABINE MODIFIED RELEASE (MR) FORMULATIONS AT STEADY STATE COMPARED TO THE IMMEDIATE RELEASE (IR) FORMULATION.: